Characteristics of intraretinal deposits in acute central serous chorioretinopathy

Código QR

Characteristics of intraretinal deposits in acute central serous chorioretinopathy

Andrea M Plateroti, Matthew T Witmer, Szilárd Kiss, Donald J D'AmicoDepartment of Ophthalmology, Weill Cornell Medical College, New York, NY, USAPurpose: To describe the temporal and spatial characteristics of intraretinal deposits in patients with acute central serous chorioreti...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Plateroti AM, Witmer MT, Kiss S, D’Amico DJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/df771725e6294583b6ac6c99539ee79b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Central serous chorioretinopathy: a pathogenetic model
por: et al, et al.
Publicado: (2011)

Transpupillary thermotherapy for atypical central serous chorioretinopathy
por: Kawamura R, et al.
Publicado: (2012)

Low-dose aspirin as treatment for central serous chorioretinopathy
por: Antonio Caccavale, et al.
Publicado: (2010)

Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy
por: Chin EK, et al.
Publicado: (2015)

Navigated focal laser photocoagulation for central serous chorioretinopathy
por: Chhablani J, et al.
Publicado: (2014)

Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
por: Karim SP, et al.
Publicado: (2013)

Forgotten exogenous corticosteroid as a cause of central serous chorioretinopathy
por: Paul W Hardwig, et al.
Publicado: (2008)

Correlation of spectral domain optical coherence tomography findings in acute central serous chorioretinopathy with visual acuity
por: Nair U, et al.
Publicado: (2012)

Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy
por: Tsakonas GD, et al.
Publicado: (2012)

Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
por: Ratanasukon M, et al.
Publicado: (2013)

Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
por: Sanguansak T, et al.
Publicado: (2015)

Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
por: Fujita K, et al.
Publicado: (2012)

Persistent subretinal fluid due to central serous chorioretinopathy after retinal detachment surgery
por: Moreno-L&oacute;pez M, et al.
Publicado: (2011)

Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy
por: Mazzolani F
Publicado: (2012)

Central Serous Chorioretinopathy: Pathogenesis and Management
por: Semeraro F, et al.
Publicado: (2019)

Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy
por: Mohabati D, et al.
Publicado: (2020)

Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
por: Alkin Z, et al.
Publicado: (2014)

Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy
por: Ambiya V, et al.
Publicado: (2016)

Treatment of central serous chorioretinopathy with topical NSAIDs
por: Bahadorani S, et al.
Publicado: (2019)

Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy
por: Abd Elhamid AH
Publicado: (2015)

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy
por: Mohabati D, et al.
Publicado: (2018)

Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study
por: Mazzolani F, et al.
Publicado: (2013)

Clinical application of optical coherence tomography in combination with functional diagnostics: advantages and limitations for diagnosis and assessment of therapy outcome in central serous chorioretinopathy
por: Schliesser JA, et al.
Publicado: (2014)

Modified Low Power Mode Laser for the Treatment of Central Serous Chorioretinopathy
por: Miura M, et al.
Publicado: (2020)

Optical coherence tomography predicts visual outcome in macula-involving rhegmatogenous retinal detachment
por: Cho M, et al.
Publicado: (2012)

Central Serous Chorioretinopathy in Elderly Patients Mimicking Occult Neovascular Age-Related Macular Degeneration
por: Adrean SD, et al.
Publicado: (2020)

Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy
por: Shimizu K, et al.
Publicado: (2017)

Oral Spironolactone versus Conservative Treatment for Non-Resolving Central Serous Chorioretinopathy in Real-Life Practice
por: Sinawat S, et al.
Publicado: (2020)

Comparison of ultra-widefield fluorescein angiography with the Heidelberg Spectralis&reg; noncontact ultra-widefield module versus the Optos&reg; Optomap&reg;
por: Witmer MT, et al.
Publicado: (2013)

Movement of intraretinal fluid from distant branch retinal vein occlusion to the submacular space
por: Otani T, et al.
Publicado: (2013)

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy
por: Mohabati D, et al.
Publicado: (2018)

Short Axial Length Is Related to Asymmetric Vortex Veins in Central Serous Chorioretinopathy
por: Nobuhiro Terao, MD, PhD, et al.
Publicado: (2021)

Intraretinal hyperreflective foci on spectral-domain optical coherence tomographic images of patients with retinitis pigmentosa
por: Kuroda M, et al.
Publicado: (2014)

Central serous papillopathy by optic nerve head drusen
por: Ana Marina Suelves, et al.
Publicado: (2010)

Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy
por: Asahi MG, et al.
Publicado: (2017)

Electroretinographic findings in transplant chorioretinopathy
por: Brian T Chan-Kai, et al.
Publicado: (2010)

Going green – treatment outcome and safety profile of chronic central serous chorioretinopathy treated with subthreshold green laser
por: Khatri A, et al.
Publicado: (2018)

Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life
por: Breukink MB, et al.
Publicado: (2016)

Photodynamic therapy in combination with intravitreal ziv-aflibercept and aflibercept injection in patients with chronic or repeatedly recurrent acute central serous chorioretinopathy: a single-center retrospective study
por: Doepfner JM, et al.
Publicado: (2018)

Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab
por: Takayama K, et al.
Publicado: (2012)